CD4 and systemic sclerosis: While MSCs did not significantly alter the apoptosis of CD4+PD-1+ T cells in either cohort (figure 5B), they markedly attenuated the proliferation of these cells in both patients with SSc-ILD and HCs, as measured by a CFSE assay (figure 5C).